Presentation is loading. Please wait.

Presentation is loading. Please wait.

Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series  Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo,

Published byJean-Pierre Legaré Modified over 6 years ago

Similar presentations

Presentation on theme: "Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series  Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo,"— Presentation transcript:

1 Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series 
Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo, PhD, Pierluigi Filosso, MD, Domenico Galetta, MD, Luigi Carbone, MD, Alberto Oliaro, MD, Lorenzo Spaggiari, PhD, Giacomo Cusumano, PhD, Stefano Margaritora, MD, Paolo Graziano, PhD, Pierluigi Granone, PhD  Journal of Thoracic Oncology  Volume 7, Issue 11, Pages (November 2012) DOI: /JTO.0b013e d64 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Giant malignant solitary fibrous tumor of the pleura: Preoperative evaluation with (A) computed tomography scan; (B) surgical findings, and (C) pathological macroscopic features (dimension: 320 × 250 × 170 mm; weight: 2130 g). Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Microscopical pathological findings (A) (hematoxylin and eosin × 100) of malignant solitary fibrous tumor; immunohistochemical positivity staining for (B) CD34 and (C) bcl-2. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Overall (A) LTS and (B) DFS in the entire cohort of patients. LTS, long-term survival; DFS, disease-free survival. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Prognostic factors affecting (A and B) LTS and (C and D) DFS. LTS, long-term survival; DFS, disease-free survival. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d64) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series  Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo,"

Similar presentations

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21  Marie Florescu,

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21  Marie Florescu,
Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up  Marco Lucchi, MD, Franca Melfi, MD, Paolo.

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up  Marco Lucchi, MD, Franca Melfi, MD, Paolo.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Primary malignant melanoma of the bronchus intermedius

Primary malignant melanoma of the bronchus intermedius
Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement: Anatomical versus Nonanatomical Resection  Giovanni Leuzzi, MD,

Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement: Anatomical versus Nonanatomical Resection  Giovanni Leuzzi, MD,
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program  Giulia Veronesi, MD, Massimo Bellomi, MD,

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program  Giulia Veronesi, MD, Massimo Bellomi, MD,
Long-Term Results after Treatment for Recurrent Thymoma: A Multicenter Analysis  Alberto Sandri, Giacomo Cusumano, Filippo Lococo, MD, Marco Alifano, Pierluigi.

Long-Term Results after Treatment for Recurrent Thymoma: A Multicenter Analysis  Alberto Sandri, Giacomo Cusumano, Filippo Lococo, MD, Marco Alifano, Pierluigi.
Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A
Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21  Marie Florescu,

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21  Marie Florescu,
Is Sleeve Lobectomy Comparable in Terms of Short- and Long-Term Results With Pneumonectomy After Induction Therapy? A Multicenter Analysis  Giacomo Cusumano,

Is Sleeve Lobectomy Comparable in Terms of Short- and Long-Term Results With Pneumonectomy After Induction Therapy? A Multicenter Analysis  Giacomo Cusumano,
Multimodality Treatment of Stage III Non-small Cell Lung Cancer: Analysis of a Phase II Trial Using Preoperative Cisplatin and Gemcitabine with Concurrent.

Multimodality Treatment of Stage III Non-small Cell Lung Cancer: Analysis of a Phase II Trial Using Preoperative Cisplatin and Gemcitabine with Concurrent.
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Surgery for oligometastatic non–small cell lung cancer: Long-term results from a single center experience  Maria Teresa Congedo, MD, Alfredo Cesario,

Surgery for oligometastatic non–small cell lung cancer: Long-term results from a single center experience  Maria Teresa Congedo, MD, Alfredo Cesario,

Similar presentations

Ads by Google